Novartis’ Zykadia scores priority review and breakthrough designation from FDA
February 23, 2017Sales and Marketing Novartis, zykadia
Novartis’ lung cancer treatment Zykadia (ceritinib) has been awarded both priority review and breakthrough therapy designation by the US Food …
CSO loses position at DNA sequencing company after admitting fraud
February 23, 2017Medical Communications Karmagenes
Pranav Ullal, formerly of Chief Scientific officer of Karmagenes, has been removed from his position after a paper he published …
Pfizer’s Remicade biosimilar displays similar efficacy
February 22, 2017Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra
Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …
Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics
Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
Roche and Discuva extend agreement to develop target antimicrobials
February 22, 2017Research and Development, Sales and Marketing Discuva, Roche
Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
Rabbit virus proves effective in treatment of multiple myeloma
February 22, 2017Research and Development multiple myeloma
A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …
Testosterone gel trials reveal mixed results of benefits and drawbacks
February 22, 2017Research and Development Testosterone gel, testosterone
A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …
Nativis bolsters boardroom with new director
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis
Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
The March 2017 issue of Pharmafocus is now live!
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo
The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …
FDA Priority Review for Pfizer investigational leukaemia drug
February 22, 2017Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review
Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
FDA rejects Amphastar’s application for NDA for intranasal overdose treatment
February 21, 2017Research and Development Amphastar, FDA
Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
Anti-aging study reveals role of mitochondria pointing towards new medicine
February 21, 2017Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria
A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx
February 21, 2017Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen
NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
Faulty batch of Takeda’s paracetamol discovered in Denmark
February 21, 2017Manufacturing and Production Denmark, Takeda
Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …
Merck eyes new India bio-production facility
February 21, 2017Manufacturing and Production Merck
German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …
Amygdala acquires Gilead’s candidate for addiction treatment
February 20, 2017Manufacturing and Production, Sales and Marketing Amygdala, Gilead
Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …
BlackThorn Therapeutics bring in new CEO
February 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics
BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Generic version of top-selling lung cancer drug hits Chinese market
February 20, 2017Sales and Marketing China, generics
A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis
February 20, 2017Research and Development, Sales and Marketing Celgene, multiple sclerosis
Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
Cardiovascular disease expected to place $1 trillion cost burden on US
February 20, 2017Medical Communications, Sales and Marketing cardiovascular disease
A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …
Latest content
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
